Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-17-002473
Filing Date
2017-03-16
Accepted
2017-03-16 16:45:57
Documents
4
Effectiveness Date
2017-03-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82017_actiniumpharmaceutic.htm S-8 107368
2 OPINION OF THE MATT LAW FIRM, PLLC fs82017ex5i_actiniumpharma.htm EX-5.1 6761
3 CONSENT OF GBH CPAS, PC fs82017ex23i_actiniumpharma.htm EX-23.1 1692
4 GRAPHIC ex5i_01.jpg GRAPHIC 31309
  Complete submission text file 0001213900-17-002473.txt   160152
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216746 | Film No.: 17695143
SIC: 2834 Pharmaceutical Preparations